Curium Pharma

Curium Pharma is the global leader in nuclear medicine, dedicated to providing life-changing diagnostics and treatment to patients worldwide. We develop, manufacture, and distribute world-class radiopharmaceutical products, with a strategic focus on oncology, particularly Neuroendocrine Tumors (NETs) and prostate cancer PSMA. Our mission involves exploring untapped potential for innovation, including leveraging AI to enhance image quality, improve diagnostic accuracy, and better support physicians, ultimately striving to change the face of medicine.

Built upon remarkable foundations and a proven heritage of delivering reliable nuclear solutions, Curium Pharma fosters a pioneering and collaborative environment. Our diverse team of industry experts is united by a singular focus: to supply revolutionary diagnostic and therapeutic radiopharmaceuticals with unrivaled reliability and superior service. With a global reach and plans to expand further into key markets like Japan and China, we invite you to learn more about our impact and join us in making a difference for patients globally.